99
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Design of a Modern Liposome and Bee Venom Formulation for the Traditional VIT-Venom Immunotherapy

, , , &
Pages 353-368 | Published online: 09 Dec 2008

References

  • S. H. Andriao-Escarso, A. M. Soares, V. M. Rodrigues, Y. Ângulo, C. Diaz, B. Lomonte, and et al (2000). Myotoxic phospholipases A2 in bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from bothrops jararacussu. Biochimie 82:755–763.
  • R. R. Annand, M. Kontoyanni, J. E. Penzotti, T. Duddler, T. P. Lybrand, and M. H. Gelb. (1996). Active site of bee venom phospholipase A2: role of histidine-34, aspartate-64, and tyrosine-87. Biochemistry 35:4591–4601.
  • I. T. Annila, E. S. Karjalainen, P. A. Annila, and P. A. Kuusisto. (1996). Bee and wasp sting reactions in current beekeepers. Ann Allergy Athsma Immunol 77:423–427.
  • S. E. Blondelle, and R. A. Houghten. (1991). Hemolytic and antimicrobial activities of the twenty-four individual omission analogues of melittin. Biochemistry 30:4671–4678.
  • R. Breheler, H. Wolff, B. Kutting, J. Schnitker, and T. Luger. (2000). Safety of a two-day ultrarush insect venom immunotherapy protocol comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol 105:1231–1235.
  • M. H Bueno da Costa, G. Gregoriadis, R. A. Schwendener, R. Guidolin, and P. Soares de Araujo. (2002). DEINPI/SP 002137: lipossomos e processo de obtenção de lipossomos, formulações lipossômicas, processo de obtenção e usos para a produção de soro hiperimune e método de tratamento profilático ou curativo de doenças ou distúrbios passíveis de serem tratados pela administração de soro hiperimune. (Liposomes and obtention process, liposomal formulation, obtention process and uses for hyperimmune serum production and profilactic treatment process or curative of diseases or disturbs treated by hyperimmune sera administration.)
  • M. H Bueno da Costa, G. Gregoriadis, R. A. Schwendener, R. Guidolin, and P. Soares de Araujo. (2008). Microencapsulation of venoms from poisonous animals within liposomes produced with natural phospholipids, in preparation.
  • Y. N. Chen, K. C. Li, Z. Li, G. W. Shang, Z. M. Liu, J. W. Lu, and et al (2006). Effects of bee venom peptidergic components on rat pain-related behaviors and inflammation. Neuroscience 138:631–640.
  • C. E. Dempsey. (1990). The actions of mellitin on membranes. Biochim Biophys Acta 1031:143–161.
  • G. Gregoriadis. (Ed.). (2007). Preface. In: Liposome Technology third edition, Volumes I, II, and III. New York: CRC Informa Healthcare.
  • G. Gregoriadis, B. McCormack, M. Obrenovic, R. Saffie, B. Zadi, and Y. Perrie. (1999). Vaccine entrapment in liposomes. Methods 19:156–162.
  • N. Greeenfield, and G. D. Fasman. (1969). Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8:4108–4116.
  • J. V. Guimarães, R. S. Costa, B. H. Machado, and M. A dos Reis. (2004). Cardiovascular profile after intravenous injection of Africanized bee venom in awake rats. Rev Inst Med Trop São Paulo 46:55–58.
  • J. M. Gutiérrez, and C. L. Ownby. (2003). Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity. Toxicon 42:915–931.
  • E. Habermann. (1972). Bee and wasp venoms. Science 177:314–322.
  • P. Janicki, S. W. Gumulka, P. Krzascik, and E. Habermann. (1985). The effects of apamin in rats with pretrigeminal or high spinal trans-section of the central nervous system. Toxicon 23:993–996.
  • E. H. E. Konozy, E. S. Bernardes, C. Rosa, V. Faca, L. J. Greene, and R. J. Ward. (2003). Isolation, purification, and physico-chemical characterization of a D-galactose-binding lectin from seeds of. Erythrina speciosa. Arch Biochem Biophys 410:222–229.
  • A. Martínez-Ramírez, J. L. Bella, and J. C. Stokert. (2002). Fluorogenic reaction of blood cells induced by N-bromosiccinimide. Micron 33:399–402.
  • P. Midoux, R. Mayer, and M. Monsigny. (1995). Membrane permeabilization by α-helical peptides: a flow cytometry study. Biochim Biophys Acta 1239:249–256.
  • U. R. Müller. (2003). Recent developments and future strategies for immunotherapy of insect venom allergy. Curr Opinion Allergy Clin Immunol 3:299–303.
  • A. I. Neugut, A. T. Ghatak, and R. L. Miller. (2001). Anaphylaxix in the United States: an investigation into its epidemiology. Arch Inter Med 161:15–21.
  • S. Padavattan, T. Schirmer, M. Schmidt, C. Akdis, R. Valenta, I. Mittermann, and et al (2007). Identification of a B-cell epitope of hyaluronidase, a major bee venom allergen, from its crystal structure in complex with a specific Fab. J Mol Biol 368:742–752.
  • G. Pasaoglu, B. A. Sin, and Z. Misirligil. (2006). Rush hymnoptera venom immunotherapy is efficacious and safe. J Invest Allergol Clin Immunol 16:232–238.
  • M. A. Reis, R. S. Costa, T. M. Coimbra, and V. P. Teixeira. (1998). Acute renal failure in experimental envenomation with Africanized bee venom. Ren Fail 20:39–51.
  • K. J. Riches, D. Gillis, and R. A. James. (2002). An autopsy approach to bee sting–related deaths. Pathology 34:257–262.
  • J. O. Schmidt. (1995). Toxiconology of venoms from the honeybee genus Apis. Toxicon 33:917–927.
  • R. A. Shipolini, G. L. Callewaert, R. C. Cottrell, and C. A. Vernon. (1971). The primary sequence of phospholipase A from bee venom. FEBS Lett 17:39–40.
  • C. J. Steen, C. K. Janninger, S. E. Schutzer, and R. A. Schwartz. (2005). Insect sting reactions to bees, wasps, and ants. Int Soc Derm 44:91–94.
  • O. K. Sumikura, A. M. Andersen, L. Drewes, and A. Arendt-Nielsen. (2003). Comparison of hyperalgesia and neurogenic inflammation induced by melittin and capsaicin in humans. Neurosci Lett 337:147–150.
  • X. Sun, S. Chen, S. Li, H. Yan, Y. Fan, and H. Mi. (2005). Deletion of two C-terminal Gln residues of 12–26-residue fragment of mellitin improves its antimicrobial activity. Peptides 26:369–375.
  • A. M. Tanksale, J. V. Vernekar, M. S. Ghatge, and V. V. Deshpande. (2000). Evidence for tryptophan in proximity to histidine and cysteine as essential to the active site of an alkaline protease. Biochem Biophys Res Comm 270:910–917.
  • R. Valenta. (2002). The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol 2:443–456.
  • R. S. Vetter, P. K. Visscher, and S. Camazine. (1999). Mass envenomations by honey bees and wasps. West J Med 170:223–227.
  • B. Wang, X. Wei, and W. Liu. (2004). Cleavage of supercoiled circular double-stranded DNA induced by a Eukaryotic cambialistic superoxide dismutase from Cinnamomum camphora. Acta Biochim Biophys Sinica 36:609–617.
  • World Health Organization. (2001). WHO weekly epidemiological record number 38, 21 September 2001, pp 290–296.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.